← Back to All Filings
Quest Diagnostics Director Acquires 18 Shares via Dividend Reinvestment Plan
QUEST DIAGNOSTICS INC
$DGX4CIK: 0001022079
Subscribe to track DGX
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
DGX Form 4: Director Timothy L. Main acquired 18 shares of Common Stock at $235.94 per share on 2026-10-21 via a broker dividend reinvestment plan (DRIP), totaling ~$4,246.87. Direct holdings post-transaction: 22,478 shares (plus 5,000 indirect shares via Trust).
Comprehensive Analysis
Insider Filing Overview
- Issuer: Quest Diagnostics Inc ($DGX)
- Insider: Timothy L. Main (Director)
- Transaction Date: October 21, 2026
- Filing Date: October 23, 2026
- Transaction Summary: Acquisition of 18 shares of Common Stock at $235.937 per share, totaling approximately $4,246.87.
Transaction Details
- Nature of Transaction: Acquired under Transaction Code
L, reflecting an early voluntary Form 4 reporting of shares acquired through a broker-administered dividend reinvestment plan (DRIP) eligible for Form 5 deferred reporting under Rule 16a-6. - Direct Beneficial Ownership: Following the transaction, Timothy L. Main directly holds 22,478 shares.
- Indirect Beneficial Ownership: The insider maintains an additional 5,000 shares held indirectly by Trust.
Market Significance
- Trading Significance: Low
- Key Takeaways: The transaction represents routine automatic reinvestment of dividends amounting to less than $5,000. It does not reflect discretionary open-market buying or selling and has minimal market impact.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.